ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Vincerx Pharma, Inc.
ZielBio, Inc.
Mannkind Corporation